NLM Digital Collections

Search

Start Over Genre Technical Report ✖Remove constraint Genre: Technical Report Copyright Copyright may apply ✖Remove constraint Copyright: Copyright may apply Publication Year 2019 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2019">2019</span>

43. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

Author(s):
Tice, Jeffrey A., author
Herron-Smith, Serina, author
Tsiao, Emily, author
Chapman, Rick M., author
Zaim, Remziye, author
Segel, Celia, author
Rind, David, author
Pearson, Steven D., author
Guzauskas, Greg, author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 10, 2019
Subject(s):
Immunotherapy
Peanut Hypersensitivity
United States

44. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

Author(s):
Atlas, Steven, author
Agboola, Foluso, author
Fazioli, Katherine, author
Fluetsch, Noemi, author
Kumar, Varun, author
O'Grady, Madeline, author
Rind, David, author
Pearson, Steve, author
Touchette, Daniel R., author
Boyer, Nicole, author
Talon, Brian, author
Schultz, Bob G., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Depressive Disorder, Treatment-Resistant -- drug therapy
Hallucinogens -- therapeutic use
United States

45. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Sharaf, Ravi, author
Synnott, Patricia, author
Samur, Sumeyye, author
Chapman, Rick M., author
Adair, Ellie, author
Rind, David, author
Pearson, Steve, author
O'Grady, Madeline, author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Multiple Sclerosis, Chronic Progressive -- drug therapy
Sphingosine 1 Phosphate Receptor Modulators
United States

47. Spinraza and Zolgensma for spinal muscular atrophy: effectiveness and value : final evidence report

Author(s):
Ellis, Alexandra, author
Mickle, Kristin, author
Herron-Smith, Serina, author
Kumar, Varun M., author
Cianciolo, Laura, author
Seidner, Matt, author
Rind, David, author
Pearson, Steven, author
Thokala, P. (Praveen), author
Stevenson, M. (Matt), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 24, 2019
Subject(s):
Genetic Therapy
Muscular Atrophy, Spinal -- drug therapy
United States